Artesunate dosing in severe falciparum malaria.

Artesunate dosing in severe falciparum malaria.

Bibliographic Details
Main Authors:	Dondorp, A, Maude, R, Hendriksen, I, Day, N, White, N
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Artesunate versus quinine for severe falciparum malaria - Reply
by: White, N, et al.
Published: (2006)

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
by: Dondorp, A, et al.
Published: (2005)

Population pharmacokinetics of intramuscular artesunate in african children with severe malaria: Implications for a practical dosing regimen
by: Hendriksen, I, et al.
Published: (2013)

Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.
by: Hendriksen, I, et al.
Published: (2013)

Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria
by: Haghiri, A, et al.
Published: (2023)

Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
by: Newton, P, et al.
Published: (2003)

Artesunate for severe malaria in African children Reply
by: Dondorp, A, et al.
Published: (2011)

Oral artesunate dose-response relationship in acute falciparum malaria.
by: Angus, B, et al.
Published: (2002)

The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
by: Newton, P, et al.
Published: (2006)

Development and validation of an 'in silico' decision-tool to guide optimisation of intravenous artesunate dosing regimens for severe falciparum malaria patients
by: Zaloumis, SG, et al.
Published: (2021)

Artesunate for severe malaria in African children - Authors' reply
by: Dondorp, A, et al.
Published: (2011)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
by: Das, D, et al.
Published: (2013)

Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria.
by: Bethell, D, et al.
Published: (1997)

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.
by: Phu, N, et al.
Published: (2010)

Cost-effectiveness of artesunate for the treatment of severe malaria.
by: Lubell, Y, et al.
Published: (2009)

RECTAL AND INTRAVENOUS ARTESUNATE FOR SEVERE MALARIA: MODELLING THE IMPACT OF ARTEMISININ RESISTANCE
by: Maude, R, et al.
Published: (2010)

Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.
by: Hien, T, et al.
Published: (2004)

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?
by: Maude, R, et al.
Published: (2009)

HYPOTHESES OF DRUG RESPONSE DYNAMICS TO EXPLAIN RECRUDESCENCE IN ARTESUNATE RESISTANT PLASMODIUM FALCIPARUM MALARIA
by: Maude, R, et al.
Published: (2009)

IN VIVO EVIDENCE THAT MICROCIRCULATORY OBSTRUCTION IS A CENTRAL PATHOLOGICAL PROCESS IN SEVERE FALCIPARUM MALARIA
by: Maude, R, et al.
Published: (2010)

An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria.
by: Saralamba, S, et al.
Published: (2023)

Reversibility of retinal microvascular changes in severe falciparum malaria.
by: Maude, R, et al.
Published: (2014)

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.
by: Lubell, Y, et al.
Published: (2011)

Improving the availability of artesunate for treatment of severe malaria.
by: Anstey, N, et al.
Published: (2006)

An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria.
by: Hien, T, et al.
Published: (1992)

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-saharan Africa
by: Lubell, Y, et al.
Published: (2011)

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
by: Dondorp, A, et al.
Published: (2010)

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): An open-label, randomised trial
by: Dondorp, A, et al.
Published: (2010)

Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
by: Luxemburger, C, et al.
Published: (1995)

Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria.
by: Newton, P, et al.
Published: (2000)

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial
by: Faiz, M, et al.
Published: (2005)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
by: Nosten, F
Published: (2010)

Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.
by: Hendriksen, I, et al.
Published: (2013)

A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria.
by: Newton, P, et al.
Published: (2001)

The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.
by: Krishna, S, et al.
Published: (1996)

Plasma Concentration of Parasite DNA as a Measure of Disease Severity in Falciparum Malaria.
by: Imwong, M, et al.
Published: (2014)

Magnetic resonance imaging of the brain in adults with severe falciparum malaria.
by: Maude, R, et al.
Published: (2014)

Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
by: Simpson, J, et al.
Published: (2006)

Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria.
by: Price, R, et al.
Published: (1997)

The management of severe falciparum malaria.
by: White, N
Published: (2003)